ro 48-8071 and ezetimibe

ro 48-8071 has been researched along with ezetimibe in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chuang, JC; Lopez, AM; Posey, KS; Repa, JJ; Turley, SD; Valasek, MA	1

Other Studies

1 other study(ies) available for ro 48-8071 and ezetimibe

Article	Year
Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse. Biochemical pharmacology, 2014, Apr-01, Volume: 88, Issue:3 Topics: Animals; Azetidines; Benzophenones; Cholesterol; Diet; Ezetimibe; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Mucosa; Intestine, Small; Intramolecular Transferases; Liver; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Receptors, LDL; Simvastatin; Species Specificity	2014

Article

Year

Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse.

Biochemical pharmacology, 2014, Apr-01, Volume: 88, Issue:3

Topics: Animals; Azetidines; Benzophenones; Cholesterol; Diet; Ezetimibe; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Mucosa; Intestine, Small; Intramolecular Transferases; Liver; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Receptors, LDL; Simvastatin; Species Specificity

2014